{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T13:39:33Z","timestamp":1772026773412,"version":"3.50.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T00:00:00Z","timestamp":1595376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T00:00:00Z","timestamp":1595376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004920","name":"Royan Institute","doi-asserted-by":"publisher","award":["97000115"],"award-info":[{"award-number":["97000115"]}],"id":[{"id":"10.13039\/501100004920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012021","name":"Iran University of Medical Sciences","doi-asserted-by":"crossref","award":["443"],"award-info":[{"award-number":["443"]}],"id":[{"id":"10.13039\/100012021","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Neurobiol"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s10571-020-00906-2","type":"journal-article","created":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T00:09:42Z","timestamp":1595376582000},"page":"1339-1354","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["RETRACTED ARTICLE: The Interplay of Tau Protein and \u03b2-Amyloid: While Tauopathy Spreads More Profoundly Than Amyloidopathy, Both Processes Are Almost Equally Pathogenic"],"prefix":"10.1007","volume":"41","author":[{"given":"Mahsa","family":"Pourhamzeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Taghi","family":"Joghataei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soraya","family":"Mehrabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Ahadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Mohammad Massood","family":"Hojjati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasrin","family":"Fazli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Massood","family":"Nabavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Pakdaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2153-0564","authenticated-orcid":false,"given":"Koorosh","family":"Shahpasand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,22]]},"reference":[{"key":"906_CR1","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00401-014-1254-6","volume":"127","author":"Z Ahmed","year":"2014","unstructured":"Ahmed Z, Cooper J, Murray TK et al (2014) A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity. Acta Neuropathol 127:667\u2013683. https:\/\/doi.org\/10.1007\/s00401-014-1254-6","journal-title":"Acta Neuropathol"},{"key":"906_CR2","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.bbadis.2016.01.023","volume":"1862","author":"AM Amorini","year":"2016","unstructured":"Amorini AM, Lazzarino G, Di Pietro V et al (2016) Metabolic, enzymatic and gene involvement in cerebral glucose dysmetabolism after traumatic brain injury. Biochim Biophys Acta 1862:679\u2013687. https:\/\/doi.org\/10.1016\/j.bbadis.2016.01.023","journal-title":"Biochim Biophys Acta"},{"key":"906_CR3","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jnutbio.2008.03.002","volume":"20","author":"MA Ansari","year":"2009","unstructured":"Ansari MA, Abdul HM, Joshi G et al (2009) Protective effect of quercetin in primary neurons against A\u03b2 (1\u201342): relevance to Alzheimer's disease. J Nutr Biochem 20:269\u2013275. https:\/\/doi.org\/10.1016\/j.jnutbio.2008.03.002","journal-title":"J Nutr Biochem"},{"key":"906_CR4","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.neuroscience.2004.12.022","volume":"132","author":"D Boyd-Kimball","year":"2005","unstructured":"Boyd-Kimball D, Sultana R, Poon HF et al (2005) Proteomic identification of proteins specifically oxidized by intracerebral injection of amyloid \u03b2-peptide (1\u201342) into rat brain: implications for Alzheimer\u2019s disease. Neuroscience 132:313\u2013324. https:\/\/doi.org\/10.1016\/j.neuroscience.2004.12.022","journal-title":"Neuroscience"},{"key":"906_CR5","doi-asserted-by":"publisher","first-page":"338ra66","DOI":"10.1126\/scitranslmed.aaf2362","volume":"8","author":"MR Brier","year":"2016","unstructured":"Brier MR, Gordon B, Friedrichsen K et al (2016) Tau and A\u03b2 imaging, CSF measures, and cognition in Alzheimer\u2019s disease. Sci Transl Med 8:338ra66\u2013338ra66. https:\/\/doi.org\/10.1126\/scitranslmed.aaf2362","journal-title":"Sci Transl Med"},{"key":"906_CR6","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.phrs.2018.04.017","volume":"132","author":"A Caruso","year":"2018","unstructured":"Caruso A, Nicoletti F, Mango D et al (2018) Stress as risk factor for Alzheimer\u2019s disease. Pharmacol Res 132:130\u2013134. https:\/\/doi.org\/10.1016\/j.phrs.2018.04.017","journal-title":"Pharmacol Res"},{"key":"906_CR7","doi-asserted-by":"publisher","first-page":"4857","DOI":"10.1523\/JNEUROSCI.4989-14.2015","volume":"35","author":"DL Castillo-Carranza","year":"2015","unstructured":"Castillo-Carranza DL, Guerrero-Mu\u00f1oz MJ, Sengupta U et al (2015) Tau immunotherapy modulates both pathological tau and upstream amyloid pathology in an Alzheimer's disease mouse model. J Neurosci 35:4857\u20134868. https:\/\/doi.org\/10.1523\/JNEUROSCI.4989-14.2015","journal-title":"J Neurosci"},{"key":"906_CR8","doi-asserted-by":"publisher","first-page":"17345","DOI":"10.1523\/JNEUROSCI.0172-12.2012","volume":"32","author":"MA Chabrier","year":"2012","unstructured":"Chabrier MA, Blurton-Jones M, Agazaryan AA et al (2012) Soluble A\u03b2 promotes wild-type tau pathology in vivo. J Neurosci 32:17345\u201317350. https:\/\/doi.org\/10.1523\/JNEUROSCI.0172-12.2012","journal-title":"J Neurosci"},{"key":"906_CR9","doi-asserted-by":"publisher","first-page":"9471","DOI":"10.1523\/JNEUROSCI.2838-06.2006","volume":"26","author":"JC Chavez","year":"2006","unstructured":"Chavez JC, Baranova O, Lin J et al (2006) The transcriptional activator hypoxia inducible factor 2 (HIF-2\/EPAS-1) regulates the oxygen-dependent expression of erythropoietin in cortical astrocytes. J Neurosci 26:9471\u20139481. https:\/\/doi.org\/10.1523\/JNEUROSCI.2838-06.2006","journal-title":"J Neurosci"},{"key":"906_CR10","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/ncb1901","volume":"11","author":"F Clavaguera","year":"2009","unstructured":"Clavaguera F, Bolmont T, Crowther RA et al (2009) Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol 11:909. https:\/\/doi.org\/10.1038\/ncb1901","journal-title":"Nat Cell Biol"},{"issue":"7","key":"906_CR11","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","volume":"14","author":"EE Congdon","year":"2018","unstructured":"Congdon EE, Sigurdsson EM (2018) Tau-targeting therapies for Alzheimer disease. Nat Rev Neurol 14(7):399\u2013415. https:\/\/doi.org\/10.1038\/s41582-018-0013-z","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"906_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13195-018-0341-7","volume":"10","author":"CL Dai","year":"2018","unstructured":"Dai CL, Hu W, Tung YC, Liu F, Gong CX, Iqbal K (2018) Tau passive immunization blocks seeding and spread of Alzheimer hyperphosphorylated Tau-induced pathology in 3\u00d7 Tg-AD mice. Alzheimers Res Ther 10(1):13. https:\/\/doi.org\/10.1186\/s13195-018-0341-7","journal-title":"Alzheimers Res Ther"},{"key":"906_CR13","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1016\/j.neurobiolaging.2007.02.029","volume":"29","author":"FG De Felice","year":"2008","unstructured":"De Felice FG, Wu D, Lambert MP et al (2008) Alzheimer's disease-type neuronal tau hyperphosphorylation induced by A\u03b2 oligomers. Neurobiol Aging 29:1334\u20131347. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2007.02.029","journal-title":"Neurobiol Aging"},{"key":"906_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2015.12.004","volume":"91","author":"F Di Domenico","year":"2016","unstructured":"Di Domenico F, Pupo G, Giraldo E et al (2016) Oxidative signature of cerebrospinal fluid from mild cognitive impairment and Alzheimer disease patients. Free Radic Biol Med 91:1\u20139. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2015.12.004","journal-title":"Free Radic Biol Med"},{"key":"906_CR15","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.freeradbiomed.2014.01.032","volume":"69","author":"V Di Pietro","year":"2014","unstructured":"Di Pietro V, Lazzarino G, Amorini AM et al (2014) Neuroglobin expression and oxidant\/antioxidant balance after graded traumatic brain injury in the rat. Free Radic Biol Med 69:258\u2013264. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2014.01.032","journal-title":"Free Radic Biol Med"},{"key":"906_CR16","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1176\/appi.ajp.2017.17040442","volume":"175","author":"NJ Donovan","year":"2018","unstructured":"Donovan NJ, Locascio JJ, Marshall GA et al (2018) Longitudinal association of amyloid beta and anxious-depressive symptoms in cognitively normal older adults. Am J Psychiatry 175:530\u2013537. https:\/\/doi.org\/10.1176\/appi.ajp.2017.17040442","journal-title":"Am J Psychiatry"},{"key":"906_CR17","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1056\/NEJMoa1812840","volume":"380","author":"MF Egan","year":"2019","unstructured":"Egan MF, Kost J, Voss T et al (2019) Randomized trial of verubecestat for prodromal alzheimer\u2019s disease. N Engl J Med 380:1408\u20131420. https:\/\/doi.org\/10.1056\/NEJMoa1812840","journal-title":"N Engl J Med"},{"key":"906_CR18","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.1038\/s41598-017-02961-0","volume":"7","author":"AM El Halawany","year":"2017","unstructured":"El Halawany AM, Sayed NSE, Abdallah HM et al (2017) Protective effects of gingerol on streptozotocin-induced sporadic Alzheimer\u2019s disease: emphasis on inhibition of \u03b2-amyloid, COX-2, alpha-, beta-secretases and APH1a. Sci Rep 7:2902. https:\/\/doi.org\/10.1038\/s41598-017-02961-0","journal-title":"Sci Rep"},{"key":"906_CR19","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3389\/fnagi.2019.00112","volume":"11","author":"I Ferrer","year":"2019","unstructured":"Ferrer I, Garc\u00eda MA, Carmona M et al (2019) Involvement of oligodendrocytes in tau seeding and spreading in tauopathies. Front Aging Neurosci 11:112. https:\/\/doi.org\/10.3389\/fnagi.2019.00112","journal-title":"Front Aging Neurosci"},{"key":"906_CR20","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nature23002","volume":"547","author":"AW Fitzpatrick","year":"2017","unstructured":"Fitzpatrick AW, Falcon B, He S et al (2017) Cryo-EM structures of tau filaments from Alzheimer\u2019s disease. Nature 547:185. https:\/\/doi.org\/10.1038\/nature23002","journal-title":"Nature"},{"key":"906_CR21","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/s0197-4580(02)00019-2","volume":"23","author":"RA Floyd","year":"2002","unstructured":"Floyd RA, Hensley K (2002) Oxidative stress in brain aging: implications for therapeutics of neurodegenerative diseases. Neurobiol Aging 23:795\u2013807. https:\/\/doi.org\/10.1016\/s0197-4580(02)00019-2","journal-title":"Neurobiol Aging"},{"key":"906_CR22","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1002\/gps.1235","volume":"19","author":"T Gabryelewicz","year":"2004","unstructured":"Gabryelewicz T, Styczynska M, Pfeffer A et al (2004) Prevalence of major and minor depression in elderly persons with mild cognitive impairment\u2014MADRS factor analysis. Int J Geriatr Psychiatry 19:1168\u20131172. https:\/\/doi.org\/10.1002\/gps.1235","journal-title":"Int J Geriatr Psychiatry"},{"key":"906_CR23","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3389\/fnbeh.2014.00321","volume":"8","author":"P Galeano","year":"2014","unstructured":"Galeano P, Martino Adami PV, Do Carmo S et al (2014) Longitudinal analysis of the behavioral phenotype in a novel transgenic rat model of early stages of Alzheimer's disease. Front Neurosci 8:321. https:\/\/doi.org\/10.3389\/fnbeh.2014.00321","journal-title":"Front Neurosci"},{"issue":"2\u20133","key":"906_CR24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/s0014-5793(00)02196-7","volume":"485","author":"GM Gibb","year":"2000","unstructured":"Gibb GM, Pearce J, Betts JC, Lovestone S, Hoffmann MM, Maerz W, Blackstock WP, Anderton BH (2000) Differential effects of apolipoprotein E isoforms on phosphorylation at specific sites on tau by glycogen synthase kinase-3\u03b2 identified by nano-electrospray mass spectrometry. FEBS Lett 485(2\u20133):99\u2013103. https:\/\/doi.org\/10.1016\/s0014-5793(00)02196-7","journal-title":"FEBS Lett"},{"key":"906_CR25","doi-asserted-by":"publisher","first-page":"9870","DOI":"10.1038\/s41598-019-46306-5","volume":"9","author":"E Gibbs","year":"2019","unstructured":"Gibbs E, Silverman JM, Zhao B et al (2019) A rationally designed humanized antibody selective for amyloid beta oligomers in Alzheimer\u2019s disease. Sci Rep 9:9870. https:\/\/doi.org\/10.1038\/s41598-019-46306-5","journal-title":"Sci Rep"},{"key":"906_CR26","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s00401-019-02053-5","volume":"138","author":"LA Gomes","year":"2019","unstructured":"Gomes LA, Hipp SA, Upadhaya AR et al (2019) A\u03b2-induced acceleration of Alzheimer-related \u03c4-pathology spreading and its association with prion protein. Acta Neuropathol 138:913\u2013941. https:\/\/doi.org\/10.1007\/s00401-019-02053-5","journal-title":"Acta Neuropathol"},{"key":"906_CR27","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1155\/2015\/604658","volume":"34","author":"X Gu","year":"2013","unstructured":"Gu X, Sun J, Li S et al (2013) Oxidative stress induces DNA demethylation and histone acetylation in SH-SY5Y cells: potential epigenetic mechanisms in gene transcription in A\u03b2 production. Oxid Med Cell Longev 34:1069\u20131079. https:\/\/doi.org\/10.1155\/2015\/604658","journal-title":"Oxid Med Cell Longev"},{"key":"906_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/neuro.24.003.2010","volume":"2","author":"M Guglielmotto","year":"2010","unstructured":"Guglielmotto M, Giliberto L, Tamagno E et al (2010) Oxidative stress mediates the pathogenic effect of different Alzheimer's disease risk factors. Front Aging Neurosci 2:3. https:\/\/doi.org\/10.3389\/neuro.24.003.2010","journal-title":"Front Aging Neurosci"},{"key":"906_CR29","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/nm.3457","volume":"20","author":"JL Guo","year":"2014","unstructured":"Guo JL, Lee VMY (2014) Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases. Nat Med 20:130. https:\/\/doi.org\/10.1038\/nm.3457","journal-title":"Nat Med"},{"key":"906_CR30","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.neuroscience.2011.07.012","volume":"194","author":"X Guo","year":"2011","unstructured":"Guo X, Wu X, Ren L et al (2011) Epigenetic mechanisms of amyloid-\u03b2 production in anisomycin-treated SH-SY5Y cells. Neuroscience 194:272\u2013281. https:\/\/doi.org\/10.1016\/j.neuroscience.2011.07.012","journal-title":"Neuroscience"},{"key":"906_CR31","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.tibtech.2017.06.002","volume":"35","author":"MJ Hajipour","year":"2017","unstructured":"Hajipour MJ, Santoso MR, Rezaee F et al (2017) Advances in alzheimer\u2019s diagnosis and therapy: the implications of nanotechnology. Trends Biotechnol 35:937\u2013953. https:\/\/doi.org\/10.1016\/j.tibtech.2017.06.002","journal-title":"Trends Biotechnol"},{"key":"906_CR32","doi-asserted-by":"publisher","DOI":"10.1093\/acprof:oso\/9780198717478.001.0001","volume-title":"Free radicals in biology and medicine","author":"B Halliwell","year":"2015","unstructured":"Halliwell B, Gutteridge JM (2015) Free radicals in biology and medicine. Oxford University Press, Oxford"},{"key":"906_CR33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nm.4443","volume":"24","author":"Z He","year":"2018","unstructured":"He Z, Guo JL, McBride JD et al (2018) Amyloid-\u03b2 plaques enhance Alzheimer's brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation. Nat Med 24:29. https:\/\/doi.org\/10.1038\/nm.4443","journal-title":"Nat Med"},{"issue":"4","key":"906_CR34","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1056\/NEJMoa1705971","volume":"378","author":"LS Honig","year":"2018","unstructured":"Honig LS, Vellas B, Woodward M, Boada M, Bullock R, Borrie M, Hager K, Andreasen N, Scarpini E, Liu-Seifert H, Case M (2018) Trial of solanezumab for mild dementia due to Alzheimer\u2019s disease. N Engl J Med 378(4):321\u2013330. https:\/\/doi.org\/10.1056\/NEJMoa1705971","journal-title":"N Engl J Med"},{"key":"906_CR35","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s11033-018-4501-4","volume":"46","author":"E Hooshmandi","year":"2019","unstructured":"Hooshmandi E, Ghasemi R, Iloun P et al (2019) The neuroprotective effect of agmatine against amyloid \u03b2-induced apoptosis in primary cultured hippocampal cells involving ERK, Akt\/GSK-3\u03b2, and TNF-\u03b1. Mol Biol Rep 46:489\u2013496. https:\/\/doi.org\/10.1007\/s11033-018-4501-4","journal-title":"Mol Biol Rep"},{"key":"906_CR36","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","volume":"9","author":"CR Jack Jr","year":"2010","unstructured":"Jack CR Jr, Knopman DS, Jagust WJ et al (2010) Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 9:119\u2013128. https:\/\/doi.org\/10.1016\/S1474-4422(09)70299-6","journal-title":"Lancet Neurol"},{"key":"906_CR37","doi-asserted-by":"publisher","first-page":"3174","DOI":"10.1074\/jbc.R115.702704","volume":"291","author":"HH Jarosz-Griffiths","year":"2016","unstructured":"Jarosz-Griffiths HH, Noble E, Rushworth JV et al (2016) Amyloid-\u03b2 receptors: the good, the bad, and the prion protein. J Biol Chem 291:3174\u20133183. https:\/\/doi.org\/10.1074\/jbc.R115.702704","journal-title":"J Biol Chem"},{"key":"906_CR38","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/s41582-019-0259-0","volume":"15","author":"FJNRN Jessen","year":"2019","unstructured":"Jessen FJNRN (2019) Refining the understanding of typical Alzheimer disease. Nat Rev Neurol 15:623\u2013624. https:\/\/doi.org\/10.1038\/s41582-019-0259-0","journal-title":"Nat Rev Neurol"},{"key":"906_CR39","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nature14658","volume":"523","author":"A Kondo","year":"2015","unstructured":"Kondo A, Shahpasand K, Mannix R et al (2015) Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy. Nature 523:431. https:\/\/doi.org\/10.1038\/nature14658","journal-title":"Nature"},{"key":"906_CR40","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/srep00700","volume":"2","author":"CA Lasagna-Reeves","year":"2012","unstructured":"Lasagna-Reeves CA, Castillo-Carranza DL, Sengupta U et al (2012) Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau. Sci Rep 2:700. https:\/\/doi.org\/10.1038\/srep00700","journal-title":"Sci Rep"},{"key":"906_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-019-0063-8","volume":"4","author":"P-P Liu","year":"2019","unstructured":"Liu P-P, Xie Y, Meng X-Y et al (2019) History and progress of hypotheses and clinical trials for Alzheimer\u2019s disease. Signal Transduct Target Ther 4:1\u201322. https:\/\/doi.org\/10.1038\/s41392-019-0063-8","journal-title":"Signal Transduct Target Ther"},{"key":"906_CR42","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/s0002-9440(10)65184-x","volume":"155","author":"L-F Lue","year":"1999","unstructured":"Lue L-F, Kuo Y-M, Roher AE et al (1999) Soluble amyloid \u03b2 peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am J Pathol 155:853\u2013862. https:\/\/doi.org\/10.1016\/s0002-9440(10)65184-x","journal-title":"Am J Pathol"},{"key":"906_CR43","doi-asserted-by":"publisher","first-page":"9078","DOI":"10.1523\/JNEUROSCI.1071-09.2009","volume":"29","author":"Q-L Ma","year":"2009","unstructured":"Ma Q-L, Yang F, Rosario ER et al (2009) \u03b2-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin. J Neurosci 29:9078\u20139089. https:\/\/doi.org\/10.1523\/JNEUROSCI.1071-09.2009","journal-title":"J Neurosci"},{"key":"906_CR44","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neuron.2013.02.003","volume":"78","author":"G Mairet-Coello","year":"2013","unstructured":"Mairet-Coello G, Courchet J, Pieraut S et al (2013) The CAMKK2-AMPK kinase pathway mediates the synaptotoxic effects of A\u03b2 oligomers through Tau phosphorylation. Neuron 78:94\u2013108. https:\/\/doi.org\/10.1016\/j.neuron.2013.02.003","journal-title":"Neuron"},{"key":"906_CR45","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s40478-017-0488-7","volume":"5","author":"A Mudher","year":"2017","unstructured":"Mudher A, Colin M, Dujardin S et al (2017) What is the evidence that tau pathology spreads through prion-like propagation? Acta Neuropathol Commun 5:99. https:\/\/doi.org\/10.1186\/s40478-017-0488-7","journal-title":"Acta Neuropathol Commun"},{"issue":"2\u20133","key":"906_CR46","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1159\/000353687","volume":"13","author":"EJ Mufson","year":"2014","unstructured":"Mufson EJ, Ward S, Binder L (2014) Prefibrillar tau oligomers in mild cognitive impairment and Alzheimer's disease. Neurodegener Dis 13(2\u20133):151\u2013153. https:\/\/doi.org\/10.1159\/000353687","journal-title":"Neurodegener Dis"},{"key":"906_CR47","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.cell.2012.02.016","volume":"149","author":"K Nakamura","year":"2012","unstructured":"Nakamura K, Greenwood A, Binder L et al (2012) Proline isomer-specific antibodies reveal the early pathogenic tau conformation in Alzheimer's disease. Cell 149:232\u2013244. https:\/\/doi.org\/10.1016\/j.cell.2012.02.016","journal-title":"Cell"},{"key":"906_CR48","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1021\/acschemneuro.8b00629","volume":"10","author":"R Naserkhaki","year":"2019","unstructured":"Naserkhaki R, Zamanzadeh S, Baharvand H et al (2019) cis pT231-tau drives neurodegeneration in bipolar disorder. ACS Chem Neurosci 10:1214\u20131221. https:\/\/doi.org\/10.1021\/acschemneuro.8b00629","journal-title":"ACS Chem Neurosci"},{"key":"906_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/NEN.0b013e3181919a48","volume":"68","author":"PT Nelson","year":"2009","unstructured":"Nelson PT, Braak H, Markesbery WR et al (2009) Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship. J Neuropathol Exp Neurol 68:1\u201314. https:\/\/doi.org\/10.1097\/NEN.0b013e3181919a48","journal-title":"J Neuropathol Exp Neurol"},{"key":"906_CR50","volume-title":"The rat brain in stereotaxic coordinates in stereotaxic coordinates","author":"G Paxinos","year":"2007","unstructured":"Paxinos G, Watson C (2007) The rat brain in stereotaxic coordinates in stereotaxic coordinates. Elsevier, Amsterdam"},{"issue":"1","key":"906_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-019-0063-8","volume":"4","author":"L Pei-Pei","year":"2019","unstructured":"Pei-Pei L, Yi X, Xiao-Yan M, Jian-Sheng K (2019) History and progress of hypotheses and clinical trials for Alzheimer\u2019s disease. Signal Transduct Target Ther 4(1):1\u201322. https:\/\/doi.org\/10.1038\/s41392-019-0063-8","journal-title":"Signal Transduct Target Ther"},{"key":"906_CR52","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.neurobiolaging.2017.09.024","volume":"61","author":"NS Pentkowski","year":"2018","unstructured":"Pentkowski NS, Berkowitz LE, Thompson SM et al (2018) Anxiety-like behavior as an early endophenotype in the TgF344-AD rat model of Alzheimer's disease. Neurobiol Aging 61:169\u2013176. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2017.09.024","journal-title":"Neurobiol Aging"},{"key":"906_CR53","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3389\/fnagi.2018.00250","volume":"10","author":"T Petrasek","year":"2018","unstructured":"Petrasek T, Vojtechova I, Lobellova V, Popelikova A, Janikova M, Brozka H, Houdek P, Sladek M, Sumova A, Kristofikova Z, Vales K (2018) The McGill transgenic rat model of Alzheimer's disease displays cognitive and motor impairments, changes in anxiety and social behavior, and altered circadian activity. Front Aging Neurosci 10:250. https:\/\/doi.org\/10.3389\/fnagi.2018.00250","journal-title":"Front Aging Neurosci"},{"issue":"6938","key":"906_CR54","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nature01640","volume":"423","author":"CJ Phiel","year":"2003","unstructured":"Phiel CJ, Wilson CA, Lee VMY, Klein PS (2003) GSK-3\u03b1 regulates production of Alzheimer's disease amyloid-\u03b2 peptides. Nature 423(6938):435\u2013439. https:\/\/doi.org\/10.1038\/nature01640","journal-title":"Nature"},{"key":"906_CR55","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/352239a0","volume":"352","author":"D Quon","year":"1991","unstructured":"Quon D, Wang Y, Catalano R et al (1991) Formation of \u03b2-amyloid protein deposits in brains of transgenic mice. Nature 352:239. https:\/\/doi.org\/10.1038\/352239a0","journal-title":"Nature"},{"key":"906_CR56","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/nm.2460","volume":"17","author":"DJ Selkoe","year":"2011","unstructured":"Selkoe DJ (2011) Resolving controversies on the path to Alzheimer's therapeutics. Nat Med 17:1060. https:\/\/doi.org\/10.1038\/nm.2460","journal-title":"Nat Med"},{"key":"906_CR57","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1126\/science.1228541","volume":"337","author":"DJ Selkoe","year":"2012","unstructured":"Selkoe DJ (2012) Preventing Alzheimer\u2019s disease. Science 337:1488\u20131492. https:\/\/doi.org\/10.1126\/science.1228541","journal-title":"Science"},{"key":"906_CR58","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1152\/jappl.2000.88.4.1474","volume":"88","author":"GL Semenza","year":"2000","unstructured":"Semenza GL (2000) HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol 88:1474\u20131480. https:\/\/doi.org\/10.1152\/jappl.2000.88.4.1474","journal-title":"J Appl Physiol"},{"key":"906_CR59","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1523\/JNEUROSCI.5927-11.2012","volume":"32","author":"K Shahpasand","year":"2012","unstructured":"Shahpasand K, Uemura I, Saito T et al (2012) Regulation of mitochondrial transport and inter-microtubule spacing by tau phosphorylation at the sites hyperphosphorylated in Alzheimer's disease. J Neurosci 32:2430\u20132441. https:\/\/doi.org\/10.1523\/JNEUROSCI.5927-11.2012","journal-title":"J Neurosci"},{"key":"906_CR60","doi-asserted-by":"publisher","first-page":"e608","DOI":"10.1038\/cddis.2013.129","volume":"4","author":"C Tackenberg","year":"2013","unstructured":"Tackenberg C, Grinschgl S, Trutzel A et al (2013) NMDA receptor subunit composition determines beta-amyloid-induced neurodegeneration and synaptic loss. Cell Death Dis 4:e608. https:\/\/doi.org\/10.1038\/cddis.2013.129","journal-title":"Cell Death Dis"},{"key":"906_CR61","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13041-019-0447-2","volume":"12","author":"C Tackenberg","year":"2019","unstructured":"Tackenberg C, Nitsch RM (2019) The secreted APP ectodomain sAPP\u03b1, but not sAPP\u03b2, protects neurons against A\u03b2 oligomer-induced dendritic spine loss and increased tau phosphorylation. Mol Brain 12:27. https:\/\/doi.org\/10.1186\/s13041-019-0447-2","journal-title":"Mol Brain"},{"key":"906_CR62","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1016\/j.bbagen.2014.09.003","volume":"1840","author":"N Taki-Nakano","year":"2014","unstructured":"Taki-Nakano N, Ohzeki H, Kotera J et al (2014) Cytoprotective effects of 12-oxo phytodienoic acid, a plant-derived oxylipin jasmonate, on oxidative stress-induced toxicity in human neuroblastoma SH-SY5Y cells. Biochim Biophys Acta 1840:3413\u20133422. https:\/\/doi.org\/10.1016\/j.bbagen.2014.09.003","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"906_CR63","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00401-015-1386-3","volume":"129","author":"KL Viola","year":"2015","unstructured":"Viola KL, Klein WL (2015) Amyloid \u03b2 oligomers in Alzheimer\u2019s disease pathogenesis, treatment, and diagnosis. Acta Neuropathol 129(2):183\u2013206. https:\/\/doi.org\/10.1007\/s00401-015-1386-3","journal-title":"Acta Neuropathol"},{"key":"906_CR64","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/nprot.2006.116","volume":"1","author":"CV Vorhees","year":"2006","unstructured":"Vorhees CV, Williams MT (2006) Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc 1:848. https:\/\/doi.org\/10.1038\/nprot.2006.116","journal-title":"Nat Protoc"},{"key":"906_CR65","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/nprot.2007.44","volume":"2","author":"AA Walf","year":"2007","unstructured":"Walf AA, Frye CA (2007) The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat Protoc 2:322. https:\/\/doi.org\/10.1038\/nprot.2007.44","journal-title":"Nat Protoc"},{"key":"906_CR66","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41419-019-1786-8","volume":"10","author":"Y Wei","year":"2019","unstructured":"Wei Y, Zhou J, Wu J et al (2019) ER\u03b2 promotes A\u03b2 degradation via the modulation of autophagy. Cell Death Dis 10:565. https:\/\/doi.org\/10.1038\/s41419-019-1786-8","journal-title":"Cell Death Dis"},{"key":"906_CR67","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/1440-1681.13020","volume":"46","author":"E Zamani","year":"2019","unstructured":"Zamani E, Parviz M, Roghani M et al (2019) Key mechanisms underlying netrin-1 prevention of impaired spatial and object memory in A\u03b21\u201342 CA1-injected rats. Clin Exp Pharmacol Physiol 46:86\u201393. https:\/\/doi.org\/10.1111\/1440-1681.13020","journal-title":"Clin Exp Pharmacol Physiol"}],"updated-by":[{"DOI":"10.1007\/s10571-024-01468-3","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"record-id":"53566"},{"DOI":"10.1007\/s10571-024-01468-3","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000}}],"container-title":["Cellular and Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-020-00906-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10571-020-00906-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-020-00906-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T07:08:44Z","timestamp":1711004924000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10571-020-00906-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,22]]},"references-count":67,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["906"],"URL":"https:\/\/doi.org\/10.1007\/s10571-020-00906-2","relation":{},"ISSN":["0272-4340","1573-6830"],"issn-type":[{"value":"0272-4340","type":"print"},{"value":"1573-6830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,22]]},"assertion":[{"value":"13 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been retracted. Please see the Retraction Notice for more detail:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s10571-024-01468-3","URL":"https:\/\/doi.org\/10.1007\/s10571-024-01468-3","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All experiments were done in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (NIH Publication No. 80-23, revised 1996) and were approved by the Research and Ethics Committee of School of Medicine, Iran University of Medical Sciences (IR. IUMS.97-3-9-12815), Tehran, Iran.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"This manuscript has been approved for publication by all authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}